Upcoming events

Late-breaking trials and trial updates

Session comprising selected EuroPCR 2017 late-breaking trial submissions

Chairpersons: K.H. Kuck, W. Wijns
React@PCR Moderator: F. Della Rosa

Summary

Consult this session on Late-breaking trials and trial updates at EuroPCR 2017 to find out more about a randomised multicentre trial to evaluate the utilisation of revascularisation or optimal medical therapy for the treatment of coronary CTO (EuroCTO), results from the COMPARE-ACUTE trial, neurological complications after TAVI and Bioresorbable scaffolds vs. metallic stents in routine coronary intervention on the AIDA study.

Presentations available when logged in:

  • A randomised multicentre trial to evaluate the utilisation of revascularisation or optimal medical therapy for the treatment of coronary CTO (EuroCTO)
  • FFR guided complete revascularisation during primary angioplasty is cost saving: results from the COMPARE-ACUTE trial
  • Neurological complications after TAVI with a self-expanding bioprosthesis or surgical aortic valve replacement in patients at intermediate-risk for...
  • Bioresorbable scaffolds vs. metallic stents in routine coronary intervention - The AIDA study